$CVX Company News Exxon's 'Buffett effect' — an 11% leg

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$CVX Company News

Exxon's 'Buffett effect' — an 11% leg up over energy rivals 3:57 p.m. Jan. 21, 2014 - blogs.marketwatch.com
The biggest threat to U.S. growth is in the classroom 6:01 a.m. Jan. 16, 2014 - Vince Bertram
Chevron, UnitedHealth lead Dow industrials lower 4:01 p.m. Jan. 10, 2014 - Polya Lesova
Blue-chips hit by telecom subscriber war; Alcoa skids; airlines get lift: stock market live blog (recap) 4:20 p.m. Jan. 9, 2014 - blogs.marketwatch.com
Exxon downgraded by Citi; Chevron, ConocoPhillips preferred 10:51 a.m. Jan. 9, 2014 - blogs.marketwatch.com
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Stocks advance in final session of 2013 11:19 a.m. Dec. 31, 2013 - MarketWatch
Dow notches another record; Twitter drops 4:24 p.m. Dec. 30, 2013 - William L. Watts
Energy firms stick with oil despite natural gas moves 4:30 p.m. Dec. 16, 2013 - Claudia Assis
Exxon at record high on heels of Goldman Sachs upgrade 3:19 p.m. Dec. 16, 2013 - blogs.marketwatch.com
Investors urged to ‘stay patient’ with energy stocks 3:32 p.m. Dec. 12, 2013 - Claudia Assis
Chevron projects marred by cost overruns, delays 11:03 a.m. Dec. 12, 2013 - blogs.marketwatch.com
Facebook shares jump on S&P 500 inclusion 6:50 p.m. Dec. 11, 2013 - Wallace Witkowski
Chevron trims 2014 capital expeditures 5:31 p.m. Dec. 11, 2013 - MarketWatch.com
U.S. solar installations up 20% on-year 4:41 p.m. Dec. 11, 2013 - Claudia Assis
Let it snow: 3 natural-gas stock picks 12:50 p.m. Dec. 10, 2013 - Claudia Assis
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Value investing for retirement portfolios 6:01 a.m. Dec. 7, 2013 - Robert Powell
Investor interest in energy stocks may rise: HSBC 5:22 p.m. Dec. 6, 2013 - Claudia Assis
As Big Oil plans for carbon tax, Exxon may be better prepared than most 11:38 a.m. Dec. 5, 2013 - blogs.marketwatch.com


Oppenheimer Says Betting on Higher Oil Prices May Be Catastrophic 9:28 a.m. Today - 247WallSt.com
Chevron: 2014 A Big Year For Startups In The Gulf Of Mexico 9:02 a.m. Today - Seeking Alpha
6 Compounding Machines for Long Term Dividend Investors 4:00 a.m. Today - InvestorPlace.com
Shopping for Stocks Selling at a Discount 2:21 p.m. Jan. 21, 2014 - Barrons.com
Interesting CVX Put And Call Options For September 20th 11:10 a.m. Jan. 21, 2014 - TheStreet.com
What To Buy: Chevron Corp's Buy Recommendation Reiterated 9:05 a.m. Jan. 21, 2014 - TheStreet.com
Do Naked Puts Trump Dividends For An Income Investor? 4:47 a.m. Jan. 21, 2014 - Seeking Alpha
Exxon Shareholders: Stop Whining About Dividends 3:28 a.m. Jan. 21, 2014 - Seeking Alpha
Report: Chevron Looking to Sell $1B in Properties 4:05 p.m. Jan. 20, 2014 - Wall St. Cheat Sheet
Why You Need To Ignore 52-Week Lows 3:02 p.m. Jan. 20, 2014 - Seeking Alpha
9 Dependable Stocks For Yield And Growth In 2014 11:28 a.m. Jan. 20, 2014 - Seeking Alpha
Great Dividend Growth Stocks From United Kingdom 10:17 a.m. Jan. 20, 2014 - Seeking Alpha
Shell Unloads Australian Assets for $1.1B 10:01 a.m. Jan. 20, 2014 - FOXBusiness
Shell Sells Australian Assets 4:55 a.m. Jan. 20, 2014 - WSJ.com
Shell Issues Rare Profit Warning 5:58 p.m. Jan. 19, 2014 - WSJ.com
The ABCs Of Dividend Investing: Divi-Do Or Divi-Don't? 6:47 p.m. Jan. 17, 2014 - Seeking Alpha
Chevron's Update Does Nothing To Alter Our View Of Its Fantastic Dividend Growth Prospects 2:59 p.m. Jan. 17, 2014 - Seeking Alpha
Bloomberg: Chevron seeking buyers for $1B in U.S. assets 2:32 p.m. Jan. 17, 2014 - Seeking Alpha
Rules of the Game: Blend Large and Small 1:00 p.m. Jan. 17, 2014 - RealMoney.com
5 Basic Materials Stocks Pushing The Sector Higher 12:02 p.m. Jan. 17, 2014 - TheStreet.com


Stock Movements, Conference Call Schedules, Updated Production Guidance, and Meetings - Research Report on Chevron, YPF, Murphy Oil, Ecopetrol, and Eni 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Chevron Makes Final Investment Decision on Alder Field in the United Kingdom 7:00 a.m. Jan. 13, 2014 - BusinessWire - BZX
Chevron Issues Interim Update for Fourth Quarter 2013 4:59 p.m. Jan. 9, 2014 - BusinessWire
Critical Alerts For Yahoo, Exxon Mobil, Chevron, Alexion Pharmaceuticals, and BitAuto Released By InvestorsObserver 9:31 a.m. Jan. 8, 2014 - PR Newswire
Chevron Fourth Quarter 2013 Earnings Conference Call 1:00 p.m. Jan. 7, 2014 - GlobeNewswire
Stock Movements, Oil Discoveries, Upgraded Ratings, and Approved Projects - Research Report on Chevron, BP, Ecopetrol, Murphy Oil, and Total SA 5:29 p.m. Dec. 30, 2013 - PR Newswire
AAAResearchReports.com Research and Coverage: Chevron, Statoil, Aegean Marine Petroleum Network, and Ecopetrol 8:00 a.m. Dec. 30, 2013 - PR Newswire
New Appointments, Promotions, and Share Price Updates - Research Report on Chevron, SM Energy, Denbury, Rosetta, and Energen 8:00 a.m. Dec. 19, 2013 - PR Newswire
Chevron's 2013 Fuel Your School Program Benefits More Than 900,000 Students in 16 U.S. Communities 9:00 a.m. Dec. 17, 2013 - BusinessWire
Arkansas Family Wins 2013 Chevron Delo(R) Big Bass Boat Sweepstakes 9:07 a.m. Dec. 16, 2013 - BusinessWire
2014 Budget, Operations Report, and Open Season Extension - Research Report on Chevron, Schlumberger, ConocoPhillips, Marathon Oil, and Williams 8:00 a.m. Dec. 16, 2013 - PR Newswire
Bullish Stocks Radar: OCZ Technology Group, GenVec Inc, IAMGOLD Corp, Inc, Chevron Corporation 11:13 a.m. Dec. 12, 2013 - ACCESSWIRE
Jon M. Huntsman Jr. Elected to Chevron Board of Directors 5:00 p.m. Dec. 11, 2013 - BusinessWire
Chevron Announces $39.8 Billion Capital and Exploratory Budget for 2014 5:00 p.m. Dec. 11, 2013 - BusinessWire
Case Study: Chevron Delo Products Keeps R.E. West Transportation's Fleet Running 12:00 p.m. Dec. 9, 2013 - BusinessWire
Critical Alerts For Bank of America, UnitedHealth Group, Chevron, Amgen, and US Steel Released By InvestorsObserver 9:31 a.m. Dec. 5, 2013 - PR Newswire
New Government Strategies, Tender Offers, Acquisitions and Stock Price Updates - Research Report on Chevron, Anadarko, EOG Resources, Devon Energy and Chesapeake Energy 8:00 a.m. Dec. 4, 2013 - PR Newswire
Post-Market Data Analysis: Chevron, Statoil, Aegean Marine Petroleum Network, and Ecopetrol 8:00 a.m. Dec. 4, 2013 - PR Newswire
Chevron Increases Total Global Fund Investment to $60 Million 9:00 a.m. Dec. 2, 2013 - BusinessWire
Major Integrated Oil & Gas Companies Report Launches, Operational Updates and Share Purchases - Research Report on Exxon, Chevron, BP, Encana, and Statoil 8:00 a.m. Nov. 21, 2013 - PR Newswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading